subject area of
- A Phase II Trial with Pharmacodynamic Endpoints of the Proteasome Inhibitor Bortezomib in Patients with Metastatic Colorectal Cancer Academic Article
- A phase II study of PS-341 (Bortezomib) in advanced or metastatic urothelial cancer. A trial of the Princess Margaret Hospital and University of Chicago phase II consortia Academic Article
- A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150 Academic Article
- Adherence to Prescribing Recommendations Made on a Provincial Formulary Academic Article
- Analogues of tetramethylpyrazine affect membrane fluidity of liposomes: relationship to their biological activities Academic Article
- Atomic resolution structure of obelin: soaking with calcium enhances electron density of the second oxygen atom substituted at the C2-position of coelenterazine Academic Article
- Bortezomib Added to R-CVP Is Safe and Effective for Previously Untreated Advanced-Stage Follicular Lymphoma: A Phase II Study by the National Cancer Institute of Canada Clinical Trials Group Academic Article
- Control of oxygen free radical formation from mitochondrial complex I: roles for protein kinase A and pyruvate dehydrogenase kinase Academic Article
- Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes Academic Article
- Effects of phosphodiesterase inhibitors on normal and chemically-skinned isolated airway smooth muscle Academic Article
- Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis Academic Article
- Heterologous Expression and Structural Characterisation of a Pyrazinone Natural Product Assembly Line Academic Article
- Inhibition of Vasoconstriction by Tetramethylpyrazine Academic Article
- Inhibitory effects of tetramethyl and tetraethyl derivatives of pyrazine on dog saphenous vein Academic Article
- Optimizing dimodular nonribosomal peptide synthetases and natural dipeptides in an Escherichia coli heterologous host Academic Article
- Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non–Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations Academic Article
- Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors Academic Article
- Plant-derived drugs acting on cellular ca2+mobilization in vascular smooth muscle: Tetramethylpyrazine and tetrandrine Academic Article
- Proteasome Inhibition With Bortezomib (PS-341): A Phase I Study With Pharmacodynamic End Points Using a Day 1 and Day 4 Schedule in a 14-Day Cycle Academic Article
- Pyrazine derivatives affect membrane fluidity of vascular smooth muscle microsomes in relation to their biological activity Academic Article
- Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers Academic Article
- Selexipag for the Treatment of Pulmonary Arterial Hypertension Academic Article
- Spatial structure of the novel light-sensitive photoprotein berovin from the ctenophore Beroe abyssicola in the Ca2+-loaded apoprotein conformation state Academic Article
- Staphylococcus aureus Nonribosomal Peptide Secondary Metabolites Regulate Virulence Academic Article
- Vascular effects of tetramethylpyrazuie: direct interaction with smooth muscle α-adrenoceptors Academic Article